Duke Researchers Describe How Breast Cancer Cells Acquire Drug Resistance

A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews